Galmed Pharmaceuticals EOCN
NASDAQ EOCN
$3.03 -0.09 (-2.65%)
As of: Oct 23, 2026 · 2:50 PM EDT

Galmed Pharmaceuticals (EOCN) Net Debt Issuances and Repayments (2013 - 2023)

Updated

Analysis

Galmed Pharmaceuticals (EOCN) Net Debt Issuances and Repayments (2013 - 2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Debt Issuance (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn 11.58 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn -4.36 Bn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn -2.00 Bn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn -5.00 Mn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn 2.17 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn -2.46 Bn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn -
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -17.00 Mn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn 64.00 Mn
10 Galmed Pharmaceuticals 1.63 Mn -39.06 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2023 130,000.00
Mar 31, 2022 175,000.00
Mar 31, 2020 37,000.00
Mar 31, 2019 -199,000.00
Mar 31, 2014 7.29 Mn
Dec 31, 2013 635,000.00
Mar 31, 2013 20,000.00
API Access

Galmed Pharmaceuticals Net Debt Issuances and Repayments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-debt-issuances-and-repayments&ticker=EOCN&period=max&api_key=YOUR_API_KEY